These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15945589)

  • 41. Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
    Tchan MC; Sillence D
    J Intellect Dev Disabil; 2009 Sep; 34(3):275-9. PubMed ID: 19681008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
    Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
    Edell WS; Tunis SL
    Am J Geriatr Psychiatry; 2001; 9(3):289-97. PubMed ID: 11481138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Authors' response to comments regarding risperidone versus olanzapine Markov model.
    Value Health; 2005; 8(5):613-4. PubMed ID: 16176499
    [No Abstract]   [Full Text] [Related]  

  • 46. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
    Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
    J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia.
    Wancata J
    Int Psychogeriatr; 2004 Mar; 16(1):107-15. PubMed ID: 15191000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia.
    Durán JC; Greenspan A; Diago JI; Gallego R; Martinez G
    Int Psychogeriatr; 2005 Dec; 17(4):591-604. PubMed ID: 16202185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.
    Ruaño G; Goethe JW; Caley C; Woolley S; Holford TR; Kocherla M; Windemuth A; de Leon J
    Mol Psychiatry; 2007 May; 12(5):474-82. PubMed ID: 17199131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSM warning on atypical psychotics and stroke may be detrimental for dementia.
    Mowat D; Fowlie D; MacEwan T
    BMJ; 2004 May; 328(7450):1262. PubMed ID: 15155521
    [No Abstract]   [Full Text] [Related]  

  • 53. Risperidone versus olanzapine for the treatment of delirium.
    Kim SW; Yoo JA; Lee SY; Kim SY; Bae KY; Yang SJ; Kim JM; Shin IS; Yoon JS
    Hum Psychopharmacol; 2010; 25(4):298-302. PubMed ID: 20521319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early withdrawal in a double-blind randomized clinical trial with olanzapine and risperidone performed in adolescents with first psychosis.
    van Nimwegen L; de Haan L
    Psychopathology; 2006; 39(3):158. PubMed ID: 16531692
    [No Abstract]   [Full Text] [Related]  

  • 55. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
    J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model.
    Vera-Llonch M; Delea TE; Richardson E; Rupnow M; Grogg A; Oster G
    Value Health; 2004; 7(5):569-84. PubMed ID: 15367252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia.
    van Bruggen J; Tijssen J; Dingemans P; Gersons B; Linszen D
    Int Clin Psychopharmacol; 2003 Nov; 18(6):341-6. PubMed ID: 14571154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.
    Wooltorton E
    CMAJ; 2002 Nov; 167(11):1269-70. PubMed ID: 12451085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.